Table 1.
Variables | Value |
---|---|
Males + | 18 (51%) |
Age in years * | 7 (4–10) |
Underlying medical conditions (excluding obesity) + | 1 (3%) ** |
Obesity + | 7 (20%) |
Duration of symptoms before hospital admission in days * | 3 (3–5) |
Clinical presentation: | |
|
35 (100%) |
|
24 (69%) |
|
17 (49%) |
|
12 (34%) |
|
17 (49%) |
|
3 (9%) |
|
21 (60%) |
|
17 (49%) |
|
5 (14%) |
Length of hospitalization in days * | 12 (8–15) |
Laboratory values: * | |
|
11.7 (7.9–15.7) |
|
1.2 (1.0–2.1) |
|
206 (162–252) |
|
145 (106–211) |
|
2.4 (0.7–11.2) |
|
8.3 (5.1–17.2) |
|
567 (414–748) |
|
1084 (806–1844) |
|
35 (21–58) |
|
28 (16–54) |
|
35 (25–51) |
|
3.4 (3.3–3.7) |
|
2.8 (2.1–3.7) |
|
460 (361–567) |
|
21 (8–51) |
|
125 (58–745) |
|
4031 (2197–8772) |
|
45 (11–159) |
Abnormal findings in imaging: + | |
|
28 (80%) |
|
31 (89%) |
|
26 (74%) |
Number of organs/systems involved: + | |
|
1 (3%) |
|
6 (17%) |
|
28 (80%) |
Medications for MIS-C: + | |
|
32 (91%) |
|
31 (89%) |
|
17 (49%) |
|
29 (83%) |
|
5 (14%) |
|
1 (3%) |
|
10 (29%) |
|
21 (60%) |
WBC, white blood cells; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CRP, C-reactive protein; PCT, procalcitonin; BNP, b-type natriuretic peptide; Il2r, interleukin-2 receptor; IL6, interleukin-6; IVIG: intravenous immunoglobulins.; + number (%); * median (interquartile range); ** Pulmonary artery stenosis.